Vaccines hold potential to curb antibiotic resistance

  26 May 2022

Prevention is better than cure — but is too costly for some countries where drug-resistant bacteria are rampant

The battle against antibiotic resistance is often portrayed as a race between pharmaceutical science and bacterial evolution. Yet health experts warn that prevention is better than cure — and the potential of vaccines in combating drug-resistant infections is often overlooked. Of the six bacteria that are responsible for the most deaths linked to drug-resistance — a combined 929,000 fatalities per year — there is a licensed vaccine for just one: Streptococcus pneumoniae, which can cause pneumonia and other illnesses.

Further reading: Financial Times
Author(s): Oliver Barnes
Effective Surveillance   Smart Innovations  


Unrestricted financial support by:

Antimicrobial Resistance Fighter Coalition


JSS University


Technology Database

Display your AMR Technology, Product and Service

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!